BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15505858)

  • 1. Drug-eluting stents for secondary prevention of restenosis.
    Kastrati A
    Catheter Cardiovasc Interv; 2004 Nov; 63(3):265-6. PubMed ID: 15505858
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-eluting stents: from randomized trials to the real world.
    Saia F; Degertekin M; Lemos PA; Serruys PW
    Minerva Cardioangiol; 2004 Oct; 52(5):349-63. PubMed ID: 15514571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting coronary stents.
    Bonvini RF; Verin V
    N Engl J Med; 2005 Dec; 353(22):2404-8; author reply 2404-8. PubMed ID: 16320452
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-eluting coronary stents.
    Jneid H; Jang IK; Palacios I
    N Engl J Med; 2005 Dec; 353(22):2404-8; author reply 2404-8. PubMed ID: 16320455
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-eluting coronary stents.
    Alarcón JA; Arribas JM; Ruiz V
    N Engl J Med; 2005 Dec; 353(22):2404-8; author reply 2404-8. PubMed ID: 16319393
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-eluting coronary stents.
    Waksman R; Wolfram RM
    N Engl J Med; 2005 Dec; 353(22):2404-8; author reply 2404-8. PubMed ID: 16320451
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sirolimus-eluting vs paclitaxel-eluting stents -- the trials confirm differences in clinical outcome].
    Gil RJ
    Kardiol Pol; 2005 Nov; 63(5):574-6; discussion 577. PubMed ID: 16362868
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial.
    Pache J; Dibra A; Mehilli J; Dirschinger J; Schömig A; Kastrati A
    Eur Heart J; 2005 Jul; 26(13):1262-8. PubMed ID: 15737962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting coronary stents.
    Czupryniak L; Pawlowski M; Loba J
    N Engl J Med; 2005 Dec; 353(22):2404-8; author reply 2404-8. PubMed ID: 16320453
    [No Abstract]   [Full Text] [Related]  

  • 10. Sirolimus-eluting coronary stents.
    Sharma S; Bhambi B; Nyitray W
    N Engl J Med; 2002 Oct; 347(16):1285; author reply 1285. PubMed ID: 12393833
    [No Abstract]   [Full Text] [Related]  

  • 11. Sirolimus eluting stent fracture following angioplasty of diffuse in-stent restenosis in the right coronary artery.
    Wilczynska J; Rdzanek A; Kochman J; Horszczaruk GJ; Pietrasik A; Opolski G
    Int J Cardiol; 2007 May; 118(1):126-7. PubMed ID: 16908080
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-eluting stents: preventing restenosis.
    Slavin L; Chhabra A; Tobis JM
    Cardiol Rev; 2007; 15(1):1-12. PubMed ID: 17172878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coating.
    Hausleiter J; Kastrati A; Wessely R; Dibra A; Mehilli J; Schratzenstaller T; Graf I; Renke-Gluszko M; Behnisch B; Dirschinger J; Wintermantel E; Schömig A;
    Eur Heart J; 2005 Aug; 26(15):1475-81. PubMed ID: 15975990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of the sirolimus-eluting stents coated with bioabsorbable polymer coating in human coronary arteries.
    Ge J; Qian J; Wang X; Wang Q; Yan W; Yan Y; Fan B; Ge L; Liu X
    Catheter Cardiovasc Interv; 2007 Feb; 69(2):198-202. PubMed ID: 17195205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PTCA with drug eluting stent. 90% fewer restenoses in high risk patients].
    MMW Fortschr Med; 2004 Aug; 146(33-34):53. PubMed ID: 15526636
    [No Abstract]   [Full Text] [Related]  

  • 16. [Efficacy of sirolimus-eluting stents in diabetics with complex coronary lesions].
    Berenguer A; Mainar V; Bordes P; Valencia J; Gómez S
    Rev Esp Cardiol; 2006 Feb; 59(2):117-24. PubMed ID: 16540032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
    Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A
    Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus-eluting stents: safe and effective in the treatment of in-stent restenosis.
    Neumann FJ
    Catheter Cardiovasc Interv; 2005 Oct; 66(2):163-4. PubMed ID: 16158398
    [No Abstract]   [Full Text] [Related]  

  • 19. Percutaneous coronary intervention and drug-eluting stents.
    Yang YM; Moussa I
    CMAJ; 2005 Feb; 172(3):323-5. PubMed ID: 15684110
    [No Abstract]   [Full Text] [Related]  

  • 20. Recurrent restenosis after implantation of sirolimus-eluting stents in aorto-ostial lesions: successful treatment with polytetrafluoroethylene-covered stents.
    Gagnor A; Varbella F; Rubartelli P; Luceri S; Conte MR
    J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):201-4. PubMed ID: 18192816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.